Ezetimibe and Neutrophil count decreased - a phase IV clinical study of FDA data

Summary:

Neutrophil count decreased is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 60+ old, also take Metformin, and have Depression.

The phase IV clinical study analyzes which people have Neutrophil count decreased when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Neutrophil count decreased?

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell) is found to be associated with 1,419 drugs and 1,770 conditions by eHealthMe. Check the latest studies of Neutrophil count decreased.

On Jul, 24, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 49 people (0.16%) have Neutrophil count decreased.

Could Ezetimibe cause Neutrophil count decreased?

Among these 49 people:

What is the gender of people who have Neutrophil count decreased when taking Ezetimibe? *

female: 48.94 %
male: 51.06 %

What is the age of people who have Neutrophil count decreased when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

Metformin: 10 people, 20.41%
Allopurinol: 9 people, 18.37%
Amlodipine: 8 people, 16.33%
Acyclovir: 6 people, 12.24%
Revlimid: 6 people, 12.24%
Sulfamethoxazole And Trimethoprim: 5 people, 10.20%
Aspirin: 5 people, 10.20%
Famotidine: 5 people, 10.20%
Omega 3: 5 people, 10.20%
Pantoprazole Sodium: 5 people, 10.20%

What are other side effects people have besides Neutrophil count decreased? *

White Blood Cell Count Decreased: 20 people, 40.82%
Lymphocyte Count Decreased: 12 people, 24.49%
Fever: 10 people, 20.41%
Thrombocytopenia (decrease of platelets in blood): 8 people, 16.33%
Acute Kidney Failure: 8 people, 16.33%
Red Blood Cell Count Decreased: 8 people, 16.33%
Blood Glucose Increased: 6 people, 12.24%
Nausea (feeling of having an urge to vomit): 6 people, 12.24%
Thirst - Excessive: 6 people, 12.24%
Beta Haemolytic Streptococcal Infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue): 6 people, 12.24%

What are the existing conditions these people have? *

Depression: 10 people, 20.41%
Hyperlipidaemia (presence of excess lipids in the blood): 9 people, 18.37%
High Blood Pressure: 8 people, 16.33%
Multiple Myeloma (cancer of the plasma cells): 7 people, 14.29%
Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 12.24%
Diabetes: 4 people, 8.16%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 8.16%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 4 people, 8.16%
Ovarian Cancer (cancer of ovary): 4 people, 8.16%
Diarrhea: 4 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Neutrophil count decreased?

- Check whether Neutrophil count decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,849 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neutrophil count decreased:

Neutrophil count decreased (1,419 drugs)

Browse all the conditions that are associated with Neutrophil count decreased:

Neutrophil count decreased (1,770 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.